These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 11182366)

  • 1. Different docetaxel-induced apoptotic pathways are present in prostate cancer cell lines LNCaP and PC-3.
    Muenchen HJ; Poncza PJ; Pienta KJ
    Urology; 2001 Feb; 57(2):366-70. PubMed ID: 11182366
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of clusterin, XIAP and survivin, and their changes by camptothecin (CPT) treatment in CPT-resistant PC-3 and CPT-sensitive LNCaP cells.
    Mizutani K; Matsumoto K; Hasegawa N; Deguchi T; Nozawa Y
    Exp Oncol; 2006 Sep; 28(3):209-15. PubMed ID: 17080014
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adenovirus-mediated inhibition of survivin expression sensitizes human prostate cancer cells to paclitaxel in vitro and in vivo.
    Zhang M; Mukherjee N; Bermudez RS; Latham DE; Delaney MA; Zietman AL; Shipley WU; Chakravarti A
    Prostate; 2005 Aug; 64(3):293-302. PubMed ID: 15754318
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sequential combination of flavopiridol and docetaxel reduces the levels of X-linked inhibitor of apoptosis and AKT proteins and stimulates apoptosis in human LNCaP prostate cancer cells.
    Gomez LA; de Las Pozas A; Perez-Stable C
    Mol Cancer Ther; 2006 May; 5(5):1216-26. PubMed ID: 16731754
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Methylseleninic acid enhances taxane drug efficacy against human prostate cancer and down-regulates antiapoptotic proteins Bcl-XL and survivin.
    Hu H; Li GX; Wang L; Watts J; Combs GF; Lü J
    Clin Cancer Res; 2008 Feb; 14(4):1150-8. PubMed ID: 18281549
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 3,3'-Diindolylmethane enhances taxotere-induced apoptosis in hormone-refractory prostate cancer cells through survivin down-regulation.
    Rahman KM; Banerjee S; Ali S; Ahmad A; Wang Z; Kong D; Sakr WA
    Cancer Res; 2009 May; 69(10):4468-75. PubMed ID: 19435906
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of the inhibitors of apoptosis proteins in cisplatin-resistant prostate cancer cells.
    Nomura T; Yamasaki M; Nomura Y; Mimata H
    Oncol Rep; 2005 Oct; 14(4):993-7. PubMed ID: 16142363
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Overexpression of the cytoprotective protein clusterin decreases radiosensitivity in the human LNCaP prostate tumour model.
    Zellweger T; Kiyama S; Chi K; Miyake H; Adomat H; Skov K; Gleave ME
    BJU Int; 2003 Sep; 92(4):463-9. PubMed ID: 12930442
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pretreatment with paclitaxel enhances apo-2 ligand/tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis of prostate cancer cells by inducing death receptors 4 and 5 protein levels.
    Nimmanapalli R; Perkins CL; Orlando M; O'Bryan E; Nguyen D; Bhalla KN
    Cancer Res; 2001 Jan; 61(2):759-63. PubMed ID: 11212279
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of an intratumoral controlled release formulation of clusterin antisense oligonucleotide complexed with chitosan containing paclitaxel or docetaxel in prostate cancer xenograft models.
    Springate CM; Jackson JK; Gleave ME; Burt HM
    Cancer Chemother Pharmacol; 2005 Sep; 56(3):239-47. PubMed ID: 15864591
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Blockade of paclitaxel-induced thymidine phosphorylase expression can accelerate apoptosis in human prostate cancer cells.
    Kikuno N; Moriyama-Gonda N; Yoshino T; Yoneda T; Urakami S; Terashima M; Yoshida M; Kishi H; Shigeno K; Shiina H; Igawa M
    Cancer Res; 2004 Oct; 64(20):7526-32. PubMed ID: 15492279
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Survival of docetaxel-resistant prostate cancer cells in vitro depends on phenotype alterations and continuity of drug exposure.
    Makarovskiy AN; Siryaporn E; Hixson DC; Akerley W
    Cell Mol Life Sci; 2002 Jul; 59(7):1198-211. PubMed ID: 12222966
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Variation in the kinetics of caspase-3 activation, Bcl-2 phosphorylation and apoptotic morphology in unselected human ovarian cancer cell lines as a response to docetaxel.
    Kolfschoten GM; Hulscher TM; Duyndam MC; Pinedo HM; Boven E
    Biochem Pharmacol; 2002 Feb; 63(4):733-43. PubMed ID: 11992642
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Potentiation of paclitaxel-induced apoptosis by the novel cyclin-dependent kinase inhibitor NU6140: a possible role for survivin down-regulation.
    Pennati M; Campbell AJ; Curto M; Binda M; Cheng Y; Wang LZ; Curtin N; Golding BT; Griffin RJ; Hardcastle IR; Henderson A; Zaffaroni N; Newell DR
    Mol Cancer Ther; 2005 Sep; 4(9):1328-37. PubMed ID: 16170024
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Signal transduction pathways of taxanes-induced apoptosis.
    Ganansia-Leymarie V; Bischoff P; Bergerat JP; Holl V
    Curr Med Chem Anticancer Agents; 2003 Jul; 3(4):291-306. PubMed ID: 12769774
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulation of microtubule, apoptosis, and cell cycle-related genes by taxotere in prostate cancer cells analyzed by microarray.
    Li Y; Li X; Hussain M; Sarkar FH
    Neoplasia; 2004; 6(2):158-67. PubMed ID: 15140405
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ERK inhibitor PD98059 enhances docetaxel-induced apoptosis of androgen-independent human prostate cancer cells.
    Zelivianski S; Spellman M; Kellerman M; Kakitelashvilli V; Zhou XW; Lugo E; Lee MS; Taylor R; Davis TL; Hauke R; Lin MF
    Int J Cancer; 2003 Nov; 107(3):478-85. PubMed ID: 14506750
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Necessity of interleukin-1beta converting enzyme cascade in taxotere-initiated death signaling.
    Suzuki A; Kawabata T; Kato M
    Eur J Pharmacol; 1998 Feb; 343(1):87-92. PubMed ID: 9551718
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modulation of docetaxel-induced apoptosis and cell cycle arrest by all- trans retinoic acid in prostate cancer cells.
    Nehmé A; Varadarajan P; Sellakumar G; Gerhold M; Niedner H; Zhang Q; Lin X; Christen RD
    Br J Cancer; 2001 Jun; 84(11):1571-6. PubMed ID: 11384110
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Methylseleninic acid potentiates apoptosis induced by chemotherapeutic drugs in androgen-independent prostate cancer cells.
    Hu H; Jiang C; Ip C; Rustum YM; Lü J
    Clin Cancer Res; 2005 Mar; 11(6):2379-88. PubMed ID: 15788689
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.